Because an increased phosphorylation of ERK1/2 was also produced by acute l-DOPA treatment (which does not elicit significant AIMs), previous study suggested that the core signaling alteration associated with dyskinesia consists in an inability to desensitize the phospho-ERK1/2 response with repeated exposure to l-DOPA [35]. Here, MAPK3 is linked to Dyskinesia.